Showing results (21-30 of 57) with videos related to
Sort By:
Pageof 6
BMC Cancer|December 21, 2018
A phase II trial of recombinant MAGE-A3 protein with immunostimulant AS15 in combination with high-dose Interleukin-2 (HDIL2) induction therapy in metastatic melanomaJennifer L McQuade, Jade Homsi, Carlos A Torres-Cabala, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 13, 2006
Symptom evaluation in palliative medicine: patient report vs systematic assessmentJade Homsi, Declan Walsh, Nilo Rivera, et al.Melanoma Research|May 13, 2009
Src activation in melanoma and Src inhibitors as therapeutic agents in melanomaJade Homsi, Christopher L Cubitt, Shumin Zhang, et al.American Journal of Clinical Oncology|December 15, 2010
Predictive factors for the development of brain metastasis in advanced unresectable metastatic melanomaAgop Y Bedikian, Caimiao Wei, Michelle Detry, et al.Cancer Investigation|May 15, 2009
A phase IB trial of intravenous INO-1001 plus oral temozolomide in subjects with unresectable stage-III or IV melanomaAgop Y Bedikian, Nicholas E Papadopoulos, Kevin B Kim, et al.Melanoma Research|November 25, 2010
Does complete response to systemic therapy in patients with stage IV melanoma translate into long-term survival?Agop Y Bedikian, Marcella M Johnson, Carla L Warneke, et al.Journal of Clinical Pharmacology|October 28, 2010
Pharmacokinetics and safety of Marqibo (vincristine sulfate liposomes injection) in cancer patients with impaired liver functionAgop Y Bedikian, Jeffrey A Silverman, Nicholas E Papadopoulos, et al.Melanoma Research|December 21, 2010
Pelvic computed tomography scans for surveillance in patients with primary melanoma in the head and neckGladys C Alvarado, Nicholas E Papadopoulos, Wen-Jen Hwu, et al.Molecular Cancer Research : MCR|August 6, 2020
Merkel Cell Polyomavirus Small T Antigen Activates Noncanonical NF-κB Signaling to Promote TumorigenesisJiawei Zhao, Yuemeng Jia, Shunli Shen, et al.Cancer Immunology, Immunotherapy : CII|June 15, 2017
A phase II study of ipilimumab plus temozolomide in patients with metastatic melanomaSapna P Patel, Dae Won Kim, Roland L Bassett, et al.Pageof 6